SEC Form 4 · accession 0001288123-15-000047
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garo H Armen
Officer — Chairman & CEO
Period of report
Dec 28, 2015
Accepted (ET)
Dec 30, 2015 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001098972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 28, 2015 | S | 44,435 | $4.6165 | D | 1,388,369 | D | |
| Common Stock | Dec 28, 2015 | S | 89,917 | $4.5947 | D | 1,298,452 | D | |
| Common Stock | Dec 29, 2015 | S | 85,224 | $4.5715 | D | 1,213,228 | D | |
| Common Stock | Dec 30, 2015 | J | 162,000 | $4.63 | D | 1,051,228 | D | |
| Common StockF2 | holding | — | — | — | 220,349 | I | by Trust and Antigenics Holdings |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Dr. Armen executed the sale for tax planning purposes. Dr. Armen intends to use the net proceeds of the sale to purchase Agenus stock during an open window in 2016.
- F2Dr. Armen is trustee and has investment authority for the Garo Armen 2014 2 Year GRAT holding 216,303 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.
- F3Represents shares donated to a charitable organization.